ClinConnect ClinConnect Logo
Search / Trial NCT06071468

Registry of the Patient Experience for Carpal Tunnel Release

Launched by SONEX HEALTH, INC. · Oct 4, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Ultrasound Guided Carpal Tunnel Release Ctr Us Ectr Octr

ClinConnect Summary

This clinical trial, called the Registry of the Patient Experience for Carpal Tunnel Release, is studying the experiences of patients who are planning to have surgery for Carpal Tunnel Syndrome (CTS). The goal is to gather detailed information from a large group of patients about their experiences before and after the surgery. This will help researchers understand how well the surgery works and what patients go through during their recovery.

To participate, you need to be at least 18 years old and have been diagnosed with CTS in one or both hands. You should also have tried other treatments that didn't help. If you're chosen to join, you'll be asked to complete questionnaires about your health and recovery over the next two years. It's important to have a smartphone or email address to receive these questionnaires. The trial is currently looking for participants, and anyone interested should check if they meet the eligibility criteria. Your input could be valuable in improving treatment for others with this condition.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria 1. ≥18 years of age 2. Clinical diagnosis of unilateral or bilateral CTS 3. A clinical decision has been made to perform CTR on one or both hands 4. CTS-6 score ≥12 in the target hand(s)\* 5. Confirmatory diagnostic testing in the target hand(s)\*:
  • 1. CTR-US: Confirmatory diagnostic testing with ultrasound (median nerve cross-sectional area ≥10 mm2 in the proximal carpal tunnel region)
  • 2. ECTR or OCTR: Confirmatory electrodiagnostic testing 6. Prior failure of one or more nonsurgical treatment options (e.g., physical activity modification, bracing, splinting, corticosteroid injection) in the target hand(s) 7. Patient agrees to complete follow-up questionnaires over a 24-month period 8. Patient has a valid smart phone number and/or email address to receive and answer follow-up questionnaires
  • Note: An asterisk (\*) denotes that this criterion must be applied to the target hand for unilateral CTR procedures, or to both hands for simultaneous bilateral CTR procedures.
  • Exclusion Criteria:
  • 1. Patient meets any of the contraindications per Instruction For Use (IFU)
  • 2. Patient has other medical, social, or psychological conditions that, in the opinion of the investigator, preclude them from completing all registry requirements.

About Sonex Health, Inc.

Sonex Health, Inc. is a pioneering clinical trial sponsor dedicated to advancing innovative medical solutions in the field of healthcare. With a focus on minimally invasive procedures, the company develops and conducts clinical trials aimed at improving patient outcomes and enhancing the quality of care. Leveraging cutting-edge technology and a commitment to rigorous scientific standards, Sonex Health collaborates with healthcare professionals and regulatory bodies to ensure the safety and efficacy of its treatments. Through its research efforts, Sonex Health strives to address unmet medical needs and deliver transformative solutions that improve the lives of patients globally.

Locations

Lexington, Kentucky, United States

Oklahoma City, Oklahoma, United States

Woburn, Massachusetts, United States

Gainesville, Florida, United States

Evansville, Indiana, United States

Aventura, Florida, United States

Miami Lakes, Florida, United States

Hyannis, Massachusetts, United States

Troy, Michigan, United States

Saint Louis, Missouri, United States

Las Vegas, Nevada, United States

Salem, New Hampshire, United States

Amherst, New York, United States

Conway, South Carolina, United States

Denton, Texas, United States

Jackson, Tennessee, United States

Raleigh, North Carolina, United States

Scottsdale, Arizona, United States

Lakeland, Florida, United States

Decatur, Illinois, United States

Tulsa, Oklahoma, United States

Fort Worth, Texas, United States

Madison, Wisconsin, United States

Scottsdale, Arizona, United States

Aventura, Florida, United States

Fort Walton Beach, Florida, United States

Gainesville, Florida, United States

Lakeland, Florida, United States

Miami Lakes, Florida, United States

Decatur, Illinois, United States

Evansville, Indiana, United States

Lexington, Kentucky, United States

Hyannis, Massachusetts, United States

Woburn, Massachusetts, United States

Troy, Michigan, United States

Saint Louis, Missouri, United States

Las Vegas, Nevada, United States

Albuquerque, New Mexico, United States

Amherst, New York, United States

Raleigh, North Carolina, United States

Oklahoma City, Oklahoma, United States

Tulsa, Oklahoma, United States

Bend, Oregon, United States

Conway, South Carolina, United States

Jackson, Tennessee, United States

Denton, Texas, United States

Fort Worth, Texas, United States

Madison, Wisconsin, United States

Foley, Alabama, United States

Melbourne, Florida, United States

Edina, Minnesota, United States

Jackson, Mississippi, United States

Eugene, Oregon, United States

Meadville, Pennsylvania, United States

East Providence, Rhode Island, United States

Salem, New Hampshire, United States

State College, Pennsylvania, United States

Glastonbury, Connecticut, United States

Miami, Florida, United States

Lebanon, New Hampshire, United States

Greenville, South Carolina, United States

Patients applied

0 patients applied

Trial Officials

Victor M Marwin, MD, MBA

Principal Investigator

Bluegrass Orthopaedics

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported